2. Epigenetics PROTAC
  3. Histone Acetyltransferase PROTACs
  4. CBPD-409

CBPD-409 是一种口服有效的 CBP/p300 降解剂，DC50 为 0.2–0.4 nM。CBPD-409 在 AR+ 前列腺癌细胞系 VCaP、LNCaP 和 22Rv1 中表现出抗增殖作用，IC50 为 1.2–2.0 nM。CBPD-409 具有抗肿瘤活性 (Red: CBP inhibitor GNE049 (HY-108435); Blue: CRBN/cullin 4A Thalidomide (HY-14658); Black: Linker)。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

CBPD-409 Chemical Structure

CBPD-409 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 价格 是否有货 数量
1 mg ￥6000
3 - 5 周
5 mg   询价  
10 mg   询价  

* Please select Quantity before adding items.

Customer Review

CBPD-409 相关抗体

Top Publications Citing Use of Products

查看 Histone Acetyltransferase 亚型特异性产品:

查看所有亚型
CBP/p300 GCN5/PCAF TIP60 MOZ/MORF HBO1

查看 PROTACs 亚型特异性产品:

查看所有亚型
von Hippel-Lindau (VHL) Cereblon MDM2 cIAP1

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

CBPD-409 is an orally active PROTAC degrader for CBP/p300, with DC50 of 0.2–0.4 nM. CBPD-409 exhibits antiproliferative effects in AR+ prostate cancer cell lines VCaP, LNCaP and 22Rv1, with IC50s of 1.2–2.0 nM. CBPD-409 exhibits antitumor efficacy (Red: CBP inhibitor GNE049 (HY-108435); Blue: CRBN/cullin 4A Thalidomide (HY-14658); Black: Linker)[1].

体外研究
(In Vitro)

CBPD-409 (0.01-10 nM) 抑制前列腺癌细胞 VCaP，LNCaP 和 22Rv1 中的 AR 信号转导和 c-Myc 表达[1]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

CBPD-409 相关抗体:

RT-PCR[1]

Cell Line: VCaP, LNCaP and 22Rv1
Concentration: 0.01-10 nM
Incubation Time: 6 h
Result: Reduced mRNA levels of KLK3, AR and c-Myc.
体内研究
(In Vivo)

CBPD-409 (1 mg/kg，静脉注射；3 mg/kg，口服) 在 ICR 小鼠模型中的清除率 CL 为 1.7 mL/min/kg，半衰期为 T1/2 为 2.8 小时 (静脉注射) 和 2.6 小时 (口服)，血药浓度 Cmax 为 2494 ng/mL，口服生物利用度 F=50%[1]。
CBPD-409 (0.3-1 mg/kg，口服，每天一次共 5 周) 对 VCaP 前列腺癌具有抗肿瘤活性，肿瘤生长抑制率 TGI 为 73-87%，在 VCaP 异种移植小鼠模型中没有明显毒性[1]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: VCaP xenograft CB17 SCID mice model[1]
Dosage: 0.3-1 mg/kg
Administration: p.o., once a day for 5 weeks
Result: Inhibited tumor growth with TGI of 73% (0.3 mg/kg) and 87% (1 mg/kg), without significant body weight loss.
分子量

862.97

Formula

C46H52F2N10O5
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
参考文献

CBPD-409 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

CBPD-409CBPD409CBPD 409Histone AcetyltransferasePROTACsHATsHATVCaPLNCaP22Rv1CB17 SCID miceICR miceorally activeInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
CBPD-409
目录号：
HY-158113
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z